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Abstract
Objectives—We conducted a nationwide survey to assess measles containing vaccine (MCV) 
coverage among children aged 1–9 years in Haiti and identify factors associated with vaccination 
before and during the 2012 nationwide supplementary immunisation activities (SIA).
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Methods—Haiti was stratified into five geographic regions (Metropolitan Port-au-Prince, North, 
Centre, South and West), 40 clusters were randomly selected in each region, and 35 households 
were selected per cluster.
Results—Among the 7000 visited households, 75.8% had at least one child aged 1–9 years; of 
these, 5279 (99.5%) households consented to participate in the survey. Of 9883 children enrolled, 
91% received MCV before and/or during the SIA; 31% received MR for the first time during the 
SIA, and 50.7% received two doses of MCV (one before and one during the 2012 SIA). Among 
the 1685 unvaccinated children during the SIA, the primary reason of non-vaccination was 
caregivers not being aware of the SIA (31.0%). Children aged 1–4 years had significantly lower 
MR SIA coverage than those aged 5–9 years (79.5% vs. 84.8%) (P < 0.0001). A higher proportion 
of children living in the West (12.3%) and Centre (11.2%) regions had never been vaccinated than 
in other regions (4.8–9.1%). Awareness, educational level of the mother and region were 
significantly associated with MR vaccination during and before the SIA (P < 0.001).
Conclusions—The 2012 SIA successfully increased MR coverage; however, to maintain 
measles and rubella elimination, coverage needs to be further increased among children aged 1–4 
years and in regions with lower coverage.
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Introduction
In 2007, member states of the Pan American Health Organization (PAHO) passed a 
resolution to verify and document the interruption of endemic measles and rubella virus 
transmission in the Americas (PAHO 2007). To verify and maintain the elimination of 
endemic measles and rubella, countries need to maintain high population immunity by 
achieving high two-dose vaccination coverage (≥95%), have a surveillance system able to 
detect, investigate and test all suspected measles and rubella cases and respond to detected 
cases (PAHO 2011). In addition, the Global Vaccine Action Plan highlights the need to 
achieve measles elimination in at least four WHO regions and rubella elimination in at least 
two WHO regions by 2015 (WHO 2013a).
Measles vaccine was introduced in Haiti in 1982 and was replaced by combination measles–
rubella (MR) vaccine in 2008 after a supplementary immunisation activity (SIA) that 
targeted persons aged 1–19 years. One dose of measles containing vaccine (MCV) at the age 
of 9 months is recommended in the routine immunisation schedule. Although the last 
confirmed cases of measles and rubella in Haiti were reported in 2001 and 2006, 
respectively (De Quadros et al. 2003; CDC 2008), challenges for achieving and verifying 
measles, rubella and congenital rubella syndrome (CRS) elimination include low routine 
MR coverage and a weak surveillance system. Since 2009, reported administrative 
vaccination coverage with one dose of MCV among infants aged 12 months has ranged from 
45% to 60% (WHO 2013b). In addition, a national survey conducted in 2009 found that only 
9.2% [95% confidence interval (CI): 6.0–12.4] of children aged 12–23 months had received 
MCV by the age of 10 months (Rainey et al. 2012). Since the 2010 earthquake, there was a 
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large influx into Haiti of people from a number of countries, including some where measles 
and rubella are still endemic, for humanitarian aid and other support activities, putting the 
island nation at high risk of measles and rubella virus importation.
PAHO recommends conducting periodic ‘follow-up’ SIAs to provide an additional 
opportunity to administer MR to children missed by the routine vaccination programme and 
to close immunity gaps, because the efficacy of a single measles vaccine dose is 85–95% 
(De Quadros et al. 2003; WHO 2009; Castillo-Solórzano et al. 2011). From April to June 
2012, the Haiti Ministry of Public Health and Population (French Acronym: MSPP) 
implemented several essential activities to verify and maintain measles, rubella and CRS 
elimination: (i) a nationwide MR SIA targeting children aged 9 months to 9 years regardless 
of previous vaccination history (oral polio vaccine, vitamin A and albendazole were also 
administered); (ii) active community-based and institutional searches for suspected measles, 
rubella and CRS cases; and (iii) a retrospective review of hospital records for CRS cases 
(PAHO 2012). The SIA was conducted at fixed vaccination posts (i.e. schools, markets and 
health facilities) and door-to-door in remote areas. Special vaccination cards were 
distributed to children vaccinated during the SIA.
Because of the importance of estimating population immunity for the verification of measles 
and rubella elimination (PAHO 2011), we implemented a national MR vaccination coverage 
survey following the SIA, to estimate MCV vaccination coverage and identify factors 
associated with MCV vaccination during and before the 2012 SIA.
Methods
Sampling and study population
Haiti is divided into 10 administrative departments, including Metropolitan Port-au-Prince. 
Using information from the 2011 household and population estimates provided by the 
Haitian Institute of Statistics and Information that were updated after the 2010 earthquake to 
account for population growth and movement, we combined departments to create five 
regions taking into account geographic proximity and size (Figure 1): (i) Metropolitan Port-
au-Prince; (ii) North region (Nord, Nord-Est and Nord-Ouest departments); (iii) Centre 
region (Centre and Artibonite departments); (iv) South region (Sud, Nippes and Grande 
Anse departments); and (v) West region (Ouest department (excluding Metropolitan Port-
au-Prince) and Sud-Est departments). We determined the sample size for each region 
(stratum), by assuming vaccination coverage of 85% (Rainey et al. 2011a), a desired 
precision of ±5%, a probability of achieving that precision of 0.95 and a design effect of 2 
and estimating that 28% of households visited would have a child aged 1–4 years 
(Cayemittes et al. 2007). Expected precision for national coverage based on the same 
assumptions is ±2%.
The survey was based on a stratified cluster sampling design. We used the 2011 household 
and population estimates provided by the Haitian Institute of Statistics and Information to 
randomly select 40 enumeration areas (EA) in each of the five regions by probability 
proportional to size. In each selected EA, 35 households were selected using systematic 
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sampling. We included all eligible children aged 1–9 years living in the selected households 
in the survey.
The protocol was approved by the national ethics committee in Haiti. The protocol was 
reviewed by the human subjects protection offices at CDC and PAHO and judged to not be 
human subject research (programme evaluation activity) and therefore determined to be 
exempt from review by the institutional review boards at CDC and PAHO.
Data collection
The survey was conducted from 27 July to 2 September 2012 by eight survey teams, each 
consisting of two interviewers and one supervisor. Interviewers had previous experience 
conducting national surveys [Demographic and Health Surveys (DHS)], were not employed 
by MSPP and were not involved in the SIA. Teams were trained on vaccination coverage 
survey methodology, interview strategies and use of Global Positioning System (GPS) units 
and smartphones. Upon arrival to the cluster, interviewers used GPS units with pre-loaded 
maps of the selected EA to delineate the boundaries of the EA. The first household, defined 
as a group of people who live under one roof and eat together, was selected at one of the 
corners of the EA and was marked on the map. Survey teams moved in a clockwise manner 
selecting households based on pre-assigned, investigator-determined sampling interval 
(estimated total number of households in EA/35). Selected households that were excluded 
due to ineligibility still counted towards the sample size of 35 households per EA. That is, 
they were not be replaced. Households were visited at least twice if there was no one present 
during the first visit. Interviewers obtained oral informed consent from a child’s caretaker 
before starting the interview. Caretaker interviews were conducted in Haitian Creole. If 
possible, children >5 years were interviewed at the same time as the parent because they 
might have received the vaccine at school.
The questionnaire consisted of a household component and a child component. The 
household component assessed household composition (total number of persons and total 
number of children aged 1–9 years living in the household), socio-economic characteristics 
(availability of a person with permanent employment in the household, marital status, age, 
educational level of the mother, and access to drinkable water) and caregiver awareness 
about the SIA (defined as having heard of the MR SIA conducted April–June 2012). 
Mother’s education was classified as no education (never entered school), primary (1–8 
years of school), secondary (9–12 years of school) and university (any university education). 
The child component of the questionnaire was completed for every child aged 1–9 years 
living in the household and included demographics (i.e. sex, age, date of birth), MR 
vaccination during the 2012 SIA (either by SIA vaccination card or by parental recall if the 
card was not available) and MCV vaccination before the 2012 SIA (during routine 
immunisation and/or previous SIAs, either by card or by recall) with documentation of dates 
of vaccine administration if the vaccination card was available. In addition, reasons for non-
vaccination during the 2012 SIA were assessed. To ensure that the parent understood that 
the questions referred to MR vaccination, interviewers asked specific questions to verify that 
the parent was able to correctly identify the location of the vaccination post during the SIA 
(i.e. school, market, health institution, mobile clinic), the route of vaccine administration 
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(i.e. injection) and the anatomical site of MR vaccination (i.e. arm because MR was the only 
injectable vaccine given during the 2012 SIA).
Statistical analysis
Descriptive analyses of household demographics and reasons for not being vaccinated 
during the SIA are presented as proportions and means with standard deviations where 
appropriate. Coverage estimates and 95% confidence intervals (CI) based on Taylor series 
linearisation method were calculated for the country and regions, overall and stratified by 
age and gender, separately, taking into account the sampling design (stratum, cluster and 
region-specific weight) using appropriate survey procedures in SAS v.9.3. For regional 
estimates, we assumed the sample was self-weighted; national estimates took into account 
weights based on the proportion of the total population represented in each region. Rao-
Scott chi-square tests were used to compare coverage between various subpopulations. 
Overall national MCV coverage (at least one dose, only one dose and two or more doses) 
was estimated for each birth cohort (2002–2011).
To assess factors associated with children aged 1–4 and 5–9 years being vaccinated before 
and during the 2012 SIA, one child per age group was randomly selected from each 
household. A multivariable logistic regression model, also accounting for the survey design, 
was fit including household characteristics (i.e. region, the presence of person with 
permanent job in household, caregiver awareness about the SIA) and maternal 
characteristics (i.e. marital status, education, age). Weights were adjusted to account for the 
selection probability within each household, and the presence of confounding and effect 
modification was evaluated. A P-value <0.05 was considered statistically significant.
Results
Household characteristics
Among the 7000 visited households, 5304 (75.8%) had at least one child aged 1–9 years; of 
these, 5279 (99.5%) households consented to participate in the survey. The distribution of 
participating households was as follows: 953 (18.1%) in Metropolitan Port-au-Prince, 1056 
(20.0%) in the North region, 1088 (20.6%) in the Centre region, 1088 (20.6%) in the South 
region and 1094 (20.7%) in the West region. Mean household size was 6.2 ± 2.4 persons, 
and the mean number of children aged 1–9 years residing in each household was 1.9 ± 1.0. 
Overall, 2961 (56.1%) households included a resident who was regularly employed, and 
4872 (92.3%) lacked access to treated drinking water in the house; 31.7% of households 
without access had to walk for >30 min to obtain treated drinking water. Among 
participating mothers, 65% were unmarried, 68.3% had no or primary education, and 60.4% 
were >30 years of age.
Vaccination coverage during the 2012 SIA
Overall, 4280 (80.0%) caregivers said that they were aware of the 2012 SIA. Awareness 
varied by region with the lowest awareness reported in the Centre (67.7%) and North 
(75.7%) regions and the highest in the South (89.5%), Metropolitan Port-au-Prince (86.0%) 
and West (86.8%) regions. Among households with caretakers who were aware of the SIA, 
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the principal reported sources of information about the SIA were town criers (43.1%) and 
healthcare professionals (27.8%). Radio was an important source of information in the 
Metropolitan Port-au-Prince region (24.3%).
Among the 9883 children who participated in the survey, 4849 (48.9%) were aged 1–4 years 
and 4752 (48.0%) were male. Although 89.3% of children vaccinated during the SIA 
reported receiving a card after vaccination, card retention was lower as not everyone could 
document vaccination during the SIA by card. Overall, 82.2% (95% CI: 80.2–84.1) of 
children received MR during the 2012 SIA (43.3% by card documentation and 38.9% by 
recall). MR coverage during the SIA ranged from 77.8% in the West region to 87.7% in the 
South region (Table 1). National vaccination coverage varied by age group with children 
aged 1–4 years (79.5%, 95% CI: 77.4–81.5; 46.6% by card and 32.9% by recall) having 
lower coverage than those aged 5–9 years (84.8%, 95% CI: 82.6–86.8; 39.9% by card and 
45% by recall) (P < 0.0001). The difference in coverage by age group was particularly 
pronounced in the Metropolitan Port-au-Prince (74.3% vs. 85.2%, P < 0.001), South (84.5% 
vs. 91.2%, P < 0.001) and West (74.6% vs. 80.7%, P < 0.01) regions. MR coverage did not 
differ by sex of the child (Table 1).
Among the 5279 households with an eligible child, 4120 (78%) had all eligible children 
vaccinated. There were 765 (14.5%) households with no vaccinated children; 41% of these 
households had more than one child. In 394 (7.5%) households where some but not all 
children were vaccinated, there were 491 (44%) unvaccinated children, of which 61% were 
1–4 years old.
A total of 1686 children were not vaccinated during the SIA. Of the 1685 children who 
provided reasons for non-vaccination during the SIA, the primary reasons were related to 
caregivers not being aware of the SIA (31.0%), the child being absent from home or school 
when vaccinators came (14.4%), or caregivers not knowing the place and time of the SIA 
(8.2%) (Table 2). Almost 8% of children were not vaccinated during the SIA because they 
had previously received MR; a higher proportion of these were in the Metropolitan Port-au-
Prince region (13.9%) compared with other regions (3.2–12.9%). Few caregivers reported 
lack of vaccine availability (5%); however, this was more frequently reported in the West 
region (9.4%) than in other regions (1.6–5.0%).
Vaccination coverage before the 2012 SIA
A total of 5959 (59.4%; 95% CI: 56.5–62.3) children aged 1–9 years had received MCV 
before the 2012 SIA (29.1% documented by card and 30.3% by recall). Coverage varied 
significantly by region, with highest pre-SIA coverage in the South region (69.8%, 95% CI: 
64.0– 75.6) followed by the North (64%, 95% CI: 58.6–69.4), Metropolitan Port-au-Prince 
(59%, 95% CI: 53.4–64.5), West (56.4%, 95% CI: 49.2–63.5) and Centre regions (52.1%, 
95% CI: 45.3–59.0). MCV coverage before the SIA was higher among children aged 5–9 
years (61.0%, 95% CI: 57.4–64.6; 24.6% by card and 36.4% by recall) than among those 
aged 1–4 years (57.7%, 95% CI: 54.9–60.5; 33.7% by card and 24.0% by recall) (P < 0.05). 
MCV had been received before the 2012 SIA by all 1- to 9-year-old children in 49.8% of 
households, some 1- to 9-year-old children in 18.5% of households and no 1- to 9-year-old 
children in 31.6% of households.
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Overall MCV coverage
Overall, 91% (95% CI: 89.4–92.3) of children aged 1–9 years had received at least one 
MCV dose before the 2012 SIA, during the SIA, or both, with variability in vaccination 
coverage by region and age group. A higher proportion of 1- to 4-year-olds never received 
MCV compared with those aged 5–9 years (10.6% vs. 7.6%, P < 0.001). A higher proportion 
of children living in the West (12.3%) and Centre (11.2%) regions had never been 
vaccinated than in other regions (4.8–9.1%). Overall, 31.5% of children aged 1–9 years 
received MR for the first time during the 2012 SIA, half (50.7%) received at least two MCV 
doses (a dose during the SIA and at least one dose before the SIA), and 8.7% had been 
vaccinated only before the 2012 SIA.
Measles containing vaccine coverage and number of doses received varied by year of birth 
with lowest coverage among children born in 2011. Overall, 55.4% of children born from 
2002 to 2008 had received at least two MCV doses, while only 27.2% of children born in 
2011 received two MCV doses (Table 3).
Factors associated with vaccination during the 2012 SIA and before the SIA
As shown in Table 4, factors associated with receiving MCV differed depending on the age 
group. For factors associated with vaccination during the SIA, in both age groups, a child 
living in the North, Centre and South regions was more likely to be vaccinated during the 
SIA than a child living in Metropolitan Port-au-Prince region (Table 4). A child aged 1–4 
years was less likely to be vaccinated during the SIA if a person in the household had a 
permanent job [OR=0.75 (95% CI: 0.58–0.98)] compared with a child in a household that 
did not include a person with a permanent job. Additionally, children aged 1–4 years whose 
mother had a university education were 55% less likely to be vaccinated during the SIA [OR 
= 0.45 (95% CI: 0.25–0.83)] than those whose mother did not have any education. All 
children whose caregiver was aware of the SIA were significantly more likely to be 
vaccinated.
In comparison, children aged 1–4 years whose mother had primary or higher education and 
children aged 5–9 years whose mother had secondary and higher education were two to 
three times more likely to have been vaccinated before the SIA than children whose mother 
was not educated (Table 4). Children without a mother were less likely to be vaccinated 
before the SIA.
Discussion
We found that overall, 91% of children aged 1–9 years surveyed in Haiti after the 2012 SIA 
had received at least one MCV dose; 82.2% were vaccinated during the SIA, and 59.4% 
were vaccinated before the SIA. Our findings provide evidence of a significant increase in 
MR vaccination coverage since 2010. A survey completed following an SIA conducted 
immediately after the 2010 earthquake in Metropolitan Port-au-Prince, West and Artibonite 
departments found that 65% of children aged 9 months to 5 years had received at least one 
MR dose (MSPP et al. 2011). Based on DHS findings, MCV vaccination (documented by 
card and recall) among children aged 12–23 months increased from 58% (95% CI: 53–62) in 
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2005 to 65% (95% CI: 61–69) in the DHS completed in 2012 prior to the SIA (Cayemittes et 
al. 2007; IHE & Measure DHS 2012).
What is of significance is that almost a third of the surveyed children received their first MR 
dose, and half of the children were protected with a second MCV dose during the 2012 SIA. 
This highlights the need for these ‘follow-up’ vaccination campaigns in reaching children 
who were missed during the routine immunisation and in providing an opportunity to give a 
second MCV dose to close immunity gaps. Very few studies have assessed the contribution 
of SIAs in getting unreached children. The majority of studies reported that 10–15% of 
children received their first dose of MCV during an SIA (Vijayaraghavan et al. 2007; 
Oliphant et al. 2010; Goodson et al. 2012), which is lower than our findings. This highlights 
the success of the 2012 SIA in Haiti in reaching children who were not vaccinated 
previously.
However, despite these achievements, the low reported coverage among children aged 1–4 
years requires particular attention. In 2000–2001, a measles outbreak precipitated by an 
international importation disproportionately affected children <4 years of age in Haiti, 
particularly in Metropolitan Port-au-Prince, because of low vaccination coverage in this age 
group (De Quadros et al. 2003). Furthermore, large percentages of unvaccinated children in 
Metropolitan Port-au-Prince, West and Centre regions, which are densely populated, put 
those regions at the risk of sustained measles outbreaks in the event of a virus importation. 
Targeted vaccination activities are needed in these areas to ensure that Haiti remains free of 
measles and rubella and to prevent virus importation to other countries in the Americas.
The actual proportion of children protected against measles might be lower than the 
estimated coverage suggests. In Haiti, MR vaccine is recommended at age 9 months when 
the effectiveness of a single dose of measles vaccine is estimated to be 85% versus 95% if 
received after 12 months of age (Tulchinsky et al. 1993; Orenstein et al. 2000; WHO 2009; 
Uzinanin & Zimmerman 2011). Administering a second measles vaccine dose provides 
immunity to almost 99% of recipients (Stetler et al. 1986; Christenson & Böttiger 1991; 
WHO 2009). In Haiti, half of the children received two doses of vaccine and 40% received 
one dose (estimated 85–95% immunity); hence, the actual proportion of children aged 1–9 
years protected against measles is estimated to be 85–88%. In contrast to measles vaccine, 
one dose of rubella vaccine is 95% effective (WHO 2011). To address the potential for 
vaccine failure among children vaccinated at the age of 9 months, one of the activities listed 
in the Haiti 2011–2015 comprehensive multiyear plan for immunisation is to consider 
adding a second MR [or measles–mumps–rubella (MMR)] dose to the routine vaccination 
schedule and continuing implementation of ‘follow-up’ MR campaigns.
To our knowledge, this study is the first to assess the factors associated with receiving 
vaccines during routine immunisation and vaccination campaigns. Our finding is that 
children with mothers who had secondary and higher education were more likely to be 
vaccinated before the SIA (mainly routine immunisation) than children with mothers who 
had no education are consistent with reports from other countries (Torun & Bakirci 2006; 
Rainey et al. 2011b; Bosch-Capblanch et al. 2012; Park et al. 2012). However, during the 
SIA, children <4 years old were less likely to be vaccinated if the mother was highly 
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educated. This finding could be either due to a mother’s false belief that a previously 
vaccinated child did not need to be vaccinated again or unavailability of the mother to take 
the child for vaccination during the campaign due to work commitments. Availability of a 
person with a permanent job in the household also led to lower likelihood of children aged 
1–4 years to be vaccinated during the SIA, indicating the potential lack of a caregiver during 
the day to take the child for vaccination. Hence, vaccination sessions might be needed later 
in the afternoon to accommodate the schedule of working mothers. In contrast, SIA 
participation for children aged 5–9 years, who were vaccinated predominantly in schools, 
was not associated with the mother’s educational level.
Our study reinforces the importance of complementing administrative coverage estimates 
with coverage surveys to obtain a more accurate estimate of coverage, particularly when the 
target population size is uncertain (Dietz et al. 2004). While our survey indicates that 82.2% 
of children aged 1–9 years received MR vaccine during the 2012 SIA, the administrative 
coverage estimate (calculated by dividing the number of doses of MR vaccine given during 
the SIA by the estimated number of the target population) was 117%. Inconsistencies 
between administrative and survey coverage estimates were also documented during the 
2007–2008 SIA in Haiti (Lacapère et al. 2011; Rainey et al. 2011a). Inaccuracy of 
administrative coverage estimates is also encountered in other resource poor countries 
(Murray et al. 2003; Lim et al. 2008). In Haiti, the most recent census was conducted in 
2003 and since then, particularly after the 2010 earthquake, changes in the distribution and 
size of the population have occurred. Another contributing factor to overestimating 
administrative coverage could be vaccinating children outside the target age group during 
SIAs.
This survey has several limitations. First, we had to assume that the samples within each 
region were self-weighting due to not updating the household line lists for selected EA. 
However, the sampling frame was based on recently updated data, we did improve 
representativeness using a pre-defined skip interval, and we avoided selection bias by not 
replacing households. Second, as is often the case with coverage surveys, vaccination status 
relied on caregiver recall when a card was not available. However, the survey was 
conducted one to 2 months after the completion of the SIA, which would reduce recall bias 
for the campaign, and almost all the parents could correctly identify the vaccination site, 
location and route of MR administration. For previous doses of MR vaccine, recall might be 
a limitation, especially for older children. The impact of this limitation means that the non-
sampling error could be much greater than the reported sampling error.
While elimination of endemic measles and rubella has most likely been achieved in Haiti, 
maintaining elimination is challenging particularly with the influx of international workers 
after the 2010 earthquake and wide circulation of the measles and rubella viruses globally.
After the gains in MR coverage achieved through the 2012 SIA, remaining priority activities 
include improving routine vaccination coverage to ensure protection of children <12 months 
of age, introduction of a second MCV dose in the routine childhood vaccination schedule, 
reinforcing communication messages about vaccination sessions and need to vaccinate 
children and performing more frequent and systematic mobile outreach sessions to ensure 
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that children aged <4 years, those not attending schools, and those living in regions with the 
lowest coverage are reached and vaccinated. As recommended by PAHO, SIAs will be 
needed every 3–4 years to maintain elimination and ensure high population immunity if 
routine immunisation coverage remains low.
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Figure 1. 
Regions sampled in the vaccination coverage survey – Haiti, 2012. Regions were selected as 
follows: Metropolitan Port-au-Prince region includes Port-au-Prince and the surrounding 
urban areas (Cite-Soleil, Tabarre, Delmas, Petion-ville and Carrefour); North region 
includes the Nord, Nord-Est and Nord-Ouest departments; Centre region includes the Centre 
and Artibonite departments; South region includes the Sud, Nippes and Grande Anse 
departments; and West region includes the Ouest and Sud-Est departments.
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Table 1
Estimates of measles and rubella vaccination coverage by region during the April–June 2012 nationwide 
supplementary immunisation activities (SIA)* – Haiti
Region
National
N = 9883
% (95% CI)
Metropolitan
Port-au-Prince
N = 1534
% (95% CI)
North
N = 2099
% (95% CI)
Centre
N = 2142
% (95% CI)
South
N = 2072
% (95% CI)
West
N = 2036
% (95% CI)
Overall 82.2 (80.2–84.1) 79.7 (76.3–83.0) 86.2 (81.9–89.5) 80.5 (76.6–83.9) 87.7 (84.8–91.1) 77.8 (71.4–84.2)
Age of child
 1–4 years 79.5 (77.4–81.5)† 74.3 (69.8–78.8) 84.4 (80.3–87.7) 79.2 (74.9–83.5) 84.5 (80.9–87.5) 74.6 (68.3–80.9)
 5–9 years 84.8 (82.6–86.8)† 85.2 (81.7–88.2) 87.8 (82.8–91.5) 81.8 (77.8–85.1) 91.2 (88.0–93.6) 80.7 (72.7–86.8)
Sex of child
 Male 81.7 (79.3–83.8) 80.0 (76.1–83.9) 85.2 (79.7–89.4) 79.6 (75.1–84.2) 87.5 (84.2–90.2) 77.3 (70.2–84.3)
 Female 82.7 (80.7–84.5) 79.3 (75.5–83.2) 87.1 (83.3–90.1) 81.3 (77.7–84.5) 88.0 (84.7–90.6) 78.3 (71.8–84.7)
 Total population 9 064 730 1 910 035 1 905 399 2 143 148 1 425 445 1 680 703
 Total target
  population
  (1–9 years
  old)‡
2 447 477 515 709 514 458 578 650 384 870 453 790
*Vaccination status during the SIA was assessed from special cards distributed to document vaccine doses administered during the SIA, if 
available, or by parental or child recall; CI, confidence interval.
†
Design effect (DE) and estimated intraclass correlations (ICC) = (DE – 1)/(b – 1) where b is the average number of responses per cluster, for age 
group: 1–4 years : DE = 3.4 and ICC = 0.105; and age group 5–9 years : DE = 4.8 and ICC = 0.157.
‡
Target population (children aged 1–9 years old) is estimated as 27% of the total population as recommended by the immunisation programme in 
Haiti. The total population estimates were obtained from the 2011 household, and population estimates provided by the Haitian Institute of 
Statistics and Information.
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Table 2
Reported primary reason for child not being vaccinated during the April–June 2012 nationwide supplementary 
immunisation activities (SIA), by region – Haiti
Region
Total
N = 1685
n (%)
Metropolitan
Port-au-Prince
N = 294
n (%)
North
N = 283
n (%)
Centre
N = 411
n (%)
South
N = 248
n (%)
West
N = 449
n (%)
Reasons for non-vaccination*
 Caregiver did not hear about SIA 523 (31.0) 30 (10.2) 122 (43.1) 151 (36.7) 51 (20.6) 169 (37.6)
 Child/parents were absent from school/home
  when vaccinators came
243 (14.4) 36 (12.2) 51 (18.0) 36 (8.8) 70 (28.2) 50 (11.1)
 Did not know when or where to go 138 (8.2) 40 (13.6) 14 (4.9) 46 (11.2) 10 (4.0) 28 (6.2)
 Child previously received measles–rubella
  vaccine (MR)
133 (7.9) 41 (13.9) 18 (6.4) 13 (3.2) 32 (12.9) 29 (6.5)
 Caregiver was busy/had no time 133 (7.9) 26 (8.8) 13 (4.6) 36 (8.8) 15 (6.0) 43 (9.6)
 Child was sick/had fever 87 (5.2) 21 (7.1) 9 (3.2) 23 (5.6) 15 (6.0) 19 (4.2)
 Vaccines were not available 85 (5.0) 8 (2.7) 13 (4.6) 18 (4.4) 4 (1.6) 42 (9.4)
 Vaccinator refused to vaccinate 58 (3.4) 8 (2.7) 13 (4.6) 11 (2.7) 13 (5.2) 13 (2.9)
 Did not think vaccination was important/necessary 35 (2.1) 5 (1.7) 2 (0.7) 22 (5.4) 1 (0.4) 5 (1.1)
 Does not think vaccines are safe/vaccines can
  harm the child
33 (2.0) 12 (4.1) 3 (1.1) 4 (1.0) 11 (4.4) 3 (0.7)
 Caregiver forgot to go 22 (1.3) 5 (1.7) 3 (1.1) 8 (1.9) 4 (1.6) 2 (0.4)
 Caregiver took the child but vaccinator was not
  at the vaccination site
22 (1.3) 2 (0.7) 0 (0.0) 11 (2.7) 0 (0.0) 9 (2.0)
 Child not old enough to receive MR 20 (1.2) 3 (1.0) 4 (1.4) 2 (0.5) 10 (4.0) 1 (0.2)
 Planning to vaccinate child later 18 (1.1) 10 (3.4) 3 (1.1) 1 (0.2) 3 (1.2) 1 (0.2)
 Other reasons 135 (8.0) 47 (16.0) 15 (5.3) 29 (7.1) 9 (3.6) 35 (7.8)
*Among caregivers of children who were reported not to be vaccinated, respondents were allowed to give only one primary reason.
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Table 3
Measles containing vaccine (MCV) coverage by birth cohort and number of doses received – Haiti, 2012
Year of
birth N *
Received at least
one MCV dose
% (95% CI)
Received only
one MCV dose
% (95% CI)
Received at least
two MCV doses
% (95% CI)
2002 203 90.8 (85.7–94.2) 30.5 (23.3–37.6) 60.3 (52.0–68.6)
2003 933 93.1 (91.2–94.6) 41.9 (37.8–46.0) 51.2 (46.8–55.6)
2004 1030 92.9 (90.5–94.8) 41.8 (37.8–45.9) 51.1 (46.4–55.8)
2005 1057 92.0 (89.6–93.9) 39.9 (36.1–43.8) 52.1 (47.6–56.5)
2006 1048 92.7 (90.4–94.5) 36.0 (32.2–39.7) 56.7 (52.4–61.1)
2007 1157 91.7 (89.4–93.6) 34.5 (31.6–37.5) 57.2 (53.5–60.9)
2008 1208 92.1 (89.8–93.9) 35.8 (32.8–38.8) 56.3 (52.7–59.9)
2009 1261 89.2 (86.5–91.4) 39.8 (36.6–43.0) 49.4 (45.5–53.3)
2010 1265 89.4 (87.0–91.5) 43.7 (40.2–47.2) 45.7 (41.8–49.7)
2011 718 83.5 (80.2–86.4) 56.4 (52.4–60.3) 27.2 (23.1–31.2)
Total 9880 90.9 (89.4–92.4) 40.2 (38.1–42.3) 50.7 (47.8–53.6)
*
Three children had missing years of birth.
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